Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

360 ARTÍCULOS , VIENDO DEL 226 AL 240

[Semantic memory training in Alzheimer's disease]

Goudour A, Samson S, Bakchine S, Ehrlé N.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):237-47. doi: 10.1684/pnv.2011.0272.

Alzheimer's disease: a review of recent developments

Salawu FK, Umar JT, Olokoba AB.

Ann Afr Med. 2011 Apr-Jun;10(2):73-9. doi: 10.4103/1596-3519.82057.

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial

Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S.

J Alzheimers Dis. 2011;26(3):495-505. doi: 10.3233/JAD-2011-110341.

A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease

Stein MS, Scherer SC, Ladd KS, Harrison LC.

J Alzheimers Dis. 2011;26(3):477-84. doi: 10.3233/JAD-2011-110149.

New developments in the search for a cure

Alkon DL.

W V Med J. 2011 May-Jun;107(3):10-3.

Maintaining physical fitness and function in Alzheimer's disease: a pilot study

Yu F, Savik K, Wyman JF, Bronas UG.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):406-12. doi: 10.1177/1533317511414861. Epub 2011 Jul 12.

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS.

Neurology. 2011 Aug 9;77(6):556-63. doi: 10.1212/WNL.0b013e318228bf11. Epub 2011 Jul 27.

Nanomedicine in the European Commission policy for nanotechnology

Gabellieri C, Frima H.

Nanomedicine. 2011 Oct;7(5):519-20. doi: 10.1016/j.nano.2011.07.003. Epub 2011 Jul 28.

Alzheimer's care at home: a focus on caregivers strain

Varela G, Varona L, Anderson K, Sansoni J.

Prof Inferm. 2011 Apr-Jun;64(2):113-7.

Six-month walking program changes cognitive and ADL performance in patients with Alzheimer

Venturelli M, Scarsini R, Schena F.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. doi: 10.1177/1533317511418956. Epub 2011 Aug 17.

Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study

Kavanagh S, Van Baelen B, Schäuble B.

J Alzheimers Dis. 2011;27(3):521-30. doi: 10.3233/JAD-2011-110417.

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial

Stella F, Canonici AP, Gobbi S, Galduroz RF, Cação Jde C, Gobbi LT.

Clinics (Sao Paulo). 2011;66(8):1353-60. doi: 10.1590/s1807-59322011000800008.

Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease

Viola LF, Nunes PV, Yassuda MS, Aprahamian I, Santos FS, Santos GD, Brum PS, Borges SM, Oliveira AM, Chaves GF, Ciasca EC, Ferreira RC, Paula VJ, Takeda OH, Mirandez RM, Watari R, Falcao DV, Cachioni M, Forlenza OV.

Clinics (Sao Paulo). 2011;66(8):1395-400. doi: 10.1590/s1807-59322011000800015.

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JM; ELND005-AD201 Investigators.

Neurology. 2011 Sep 27;77(13):1253-62. doi: 10.1212/WNL.0b013e3182309fa5. Epub 2011 Sep 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias